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ttps://doi.org/10.1016/j.ajpath.2018.10.007Recent fate-mapping studies in mice have provided substantial evidence that mature adult hepatocytes
are a major source of new hepatocytes after liver injury. In other systems, integrin avb8 has a major role
in activating transforming growth factor (TGF)-b, a potent inhibitor of hepatocyte proliferation. We
hypothesized that depletion of hepatocyte integrin avb8 would increase hepatocyte proliferation and
accelerate liver regeneration after injury. Using Itgb8ﬂox/ﬂox;Alb-Cre mice to deplete hepatocyte avb8,
after partial hepatectomy, hepatocyte proliferation and liver-to-body weight ratio were signiﬁcantly
increased in Itgb8ﬂox/ﬂox;Alb-Cre mice compared with control mice. Antibody-mediated blockade of he-
patocyte avb8 in vitro, with assessment of TGF-b signaling pathways by real-time quantitative PCR array,
supported the hypothesis that integrin avb8 inhibition alters hepatocyte TGF-b signaling toward a pro-
regenerative phenotype. A diethylnitrosamine-induced model of hepatocellular carcinoma, used to
examine the possibility that this pro-proliferative phenotype might be oncogenic, revealed no difference
in either tumor number or size between Itgb8ﬂox/ﬂox;Alb-Cre and control mice. Immunohistochemistry for
integrin avb8 in healthy and injured human liver demonstrated that human hepatocytes express integrin
avb8. Depletion of hepatocyte integrin avb8 results in increased hepatocyte proliferation and accelerated
liver regeneration after partial hepatectomy in mice. These data demonstrate that targeting integrin avb8
may represent a promising therapeutic strategy to drive liver regeneration in patients with a broad range
of liver diseases. (Am J Pathol 2019, 189: 258e271; https://doi.org/10.1016/j.ajpath.2018.10.007)Supported byWellcomeTrust Clinical Training Fellowship 102762/Z/13/Z
(S.N.G.), Wellcome Trust Senior Research Fellowship in Clinical Science
103749/Z/14/Z (N.C.H.),University ofCalifornia, San FranciscoLiverCenter
grant P30DK026743 (N.C.H.), andMedical Research Council Program grant
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Disclosures: None declared.Although the liver has a unique ability to regenerate, in
many cases of liver disease this regenerative capacity is
overwhelmed. A successful pro-regenerative therapy for the
liver could have widespread application, reducing the need
for transplantation in both acute and chronic liver failure,
and potentially allowing more patients with primary or
metastatic liver cancer to be treated successfully. Recent
fate-mapping studies in mice have provided strong evidence
that, in most murine models of liver injury and regeneration,
restoration of liver mass occurs predominantly through self-
duplication of hepatocytes.1,2 Hence, identifying targets that
promote proliferation and expansion of the preexistent he-
patocyte population represents an attractive therapeutic
approach to drive liver regeneration.stigative Pathology. Published by Elsevier Inc
Y license (http://creativecommons.org/licensesTransforming growth factor (TGF)-b has pleiotropic
roles in liver disease. In addition to its role as a major
proinﬂammatory cytokine,3 TGF-b is also a potent
repressor of hepatocyte proliferation.4e7 Therefore, in
principle, TGF-b inhibition appears an attractive thera-
peutic strategy to promote hepatocyte proliferation and
liver regeneration. An ideal therapy would target TGF-b.
/by/4.0).
Integrin avb8 and Liver Regenerationwith precision, allowing hepatocytes to escape the mito-
inhibitory effects of TGF-b, while not abrogating the
positive effects of TGF-b on extracellular matrix produc-
tion and vascular remodeling during the regenerative pro-
cess.8,9 Furthermore, paneTGF-b blockade may result in a
number of unwanted, off-target effects, such as induction
of autoimmunity and hepatocarcinogenesis.10e12 There-
fore, a more nuanced, selective approach that targets the
TGF-b pathway to promote liver regeneration is required.
TGF-b is predominantly stored within the extracellular
matrix in a latent state, and much of the regulation of TGF-b
function results from precise, temporally and spatially
restricted, extracellular activation of this latent complex.13
The av integrins, transmembrane heterodimeric proteins
comprising an av subunit and one of ﬁve b subunits, bind to
an arginine-glycine-aspartate (RGD) motif present on the tip
of an exposed loop within the latency-associated peptide
that maintains TGF-b in an inactive state.14 All ﬁve av
integrins have been shown to interact with the RGD motif
present in the latency-associated peptide.15e19 This
integrineRGD interaction, in the presence of mechanical
force supplied by the integrin-expressing cell, enables the
release of the active TGF-b homodimer.20
Inhibition of myoﬁbroblast av integrins in mice reduces
ﬁbrosis in multiple organs via a reduction in TGF-b activa-
tion.21 Furthermore, combined global knockout of integrins
avb6 and avb8 phenocopies the developmental effects of loss
of TGF-be1 and e3.22 In the liver, expression of integrin
avb6 appears restricted to activated cholangiocytes, transi-
tional hepatocytes, and oval cells during biliary and portal
ﬁbrosis.23,24 Conversely, avb8 expression by hepatic cell
types has not been well characterized. Integrin avb8 has been
shown to play an important role in TGF-b activation in other
systems, including dendritic cells,25e27 regulatory T cells,28
neuroepithelium,29 and in ﬁbroinﬂammatory airway dis-
ease.30 Further, integrin avb8 inhibits proliferation of lung
epithelium via TGF-b activation.31 Therefore, given the
important role of avb8 in mediating TGF-b activation in other
organ systems and pathologic processes, we investigated the
role of hepatocyte integrin avb8 in the context of liver
regeneration.We hypothesized that depletion of integrinavb8
from hepatocytes would reduce local activation of TGF-b and
would result in increased hepatocyte proliferation and accel-
erated liver regeneration after liver injury.
Materials and Methods
Mice
Albumin-Cre (Alb-Cre) mice32 were obtained from The Jack-
son Laboratory (Bar Harbor, ME), crossed with Itgb8ﬂox/ﬂox
mice33 obtained from Louis F. Reichardt (University of Cali-
fornia, San Francisco, San Francisco, CA), and the resulting
Itgb8ﬂox/ﬂox;Alb-Cre mice were maintained on a C57BL/6
background. Pdgfrb-Cre mice (also on a C57BL/6 back-
ground) were obtained from Ralf H. Adams (Max PlanckThe American Journal of Pathology - ajp.amjpathol.orgInstitute for Molecular Biomedicine and University of
Münster, Münster, Germany).34 Mice used for all experiments
were 8 to 16 weeks old and housed under speciﬁc
pathogenefree conditions in the Animal Barrier Facility of the
University of California, San Francisco, or the University of
Edinburgh, UK. Genotyping of all mice was performed by
PCR. Sample size was determined statistically before experi-
mentation.Age- and sex-matched littermate controlswere used
for all experiments. Investigators (S.N.G., K.P.M., K.H., K.S.,
M.C.D., E.E.M.S., and N.C.H.) were blinded to mouse geno-
type, and experimental order was decided randomly. All
experimental animal procedures were approved by the Insti-
tutional Animal Care and Use Committee of the University of
California, San Francisco, or performed in accordancewith the
UK Home Ofﬁce regulations.
Two-Thirds Partial Hepatectomy
Two-thirds of the liver was surgically removed under iso-
ﬂurane anesthesia as previously described.35 All surgeries
were performed in the ﬁrst half of the day. To label
proliferating hepatocytes, 5-bromo-20-deoxyuridine (BrdU;
10280879001; Sigma-Aldrich, Gillingham, UK) was injec-
ted 2 hours before liver harvest (100 mg/kg intraperitone-
ally). Mice and livers were weighed at harvest to calculate
liver-to-body weight ratio.
Hepatocarcinogenesis Model
Male mice were injected with diethylnitrosamine (25 mg/kg
intraperitoneally; Sigma-Aldrich) at 12 to 14 days. Mice
were sacriﬁced at 40 weeks, and macroscopic tumors were
counted and measured.
Liver Biochemistry
Whole blood was collected immediately after death and
allowed to clot, and serum was obtained by centrifugation
(9391  g for 5 minutes twice). Samples were frozen
at 20C pending analysis. Serum albumin, total bilirubin,
alanine transaminase, and alkaline phosphatase measure-
ments were determined by using commercial kits (Alpha
Laboratories, Eastleigh, UK, for albumin, bilirubin, and
alanine transaminase; Randox Laboratories, Crumlin,
County Antrim, UK, for alkaline phosphatase) adapted for
use on a Cobas Fara centrifugal analyzer (Roche Di-
agnostics, Welwyn Garden City, UK).
Immunohistochemistry
Liver samples were ﬁxed overnight at room temperature in
either methacarn (60% methanol, 30% chloroform, 10%
acetic acid) for BrdU immunohistochemistry (IHC) or 10%
neutral-buffered formalin. Samples were then parafﬁn-
embedded before sectioning.259
Greenhalgh et alNo image processing was performed before quantitative
analysis. Images presented in ﬁgures were contrast-
enhanced by adjusting intensity minima and maxima.
Images to be compared were processed identically and in a
manner that preserved the visibility of dim and bright
structures in the original image.
BrdU IHC
Endogenous peroxidases were quenched with 0.3% H2O2 in
methanol, followed by consecutive 10-minute incubation
steps with 0.1% trypsin (T7168; Sigma-Aldrich), warm 1.8
mol/L HCl, and 0.1 mol/L sodium tetraborate decahydrate
(S9640; Sigma-Aldrich). Blocking and subsequent incuba-
tion steps used the Mouse on Mouse Elite Peroxidase Kit
(PK2200; Vector Laboratories, Peterborough, UK). Primary
antibody was mouse anti-BrdU (dilution 1:40; M0744;
Dako, Agilent Technologies, Cheadle, UK). Detection was
performed by using the Elite Vectastain ABC kit (PK7100;
Vector Laboratories) and 3,30-diaminobenzidine (K3468;
Dako) before counterstaining, dehydration, and mounting.
For each liver sample, approximately 3000 hepatocytes
were counted to calculate the percentage of proliferating
hepatocytes.
GR1 (neutrophil)/F4/80 (Kupffer cell)/PDGFRb
(hepatic stellate cell) IHC
Antigen retrieval was performed with Tris-EDTA [platelet-
derived growth factor receptor (PDGFR)b only], endoge-
nous peroxidases were quenched with 3% H2O2, Avidin/
Biotin block was applied (SP-2001; Vector Laboratories)
before blocking with 20% goat serum (GR1/PDGFRb) or
rabbit serum (F4/80). Primary antibodies were applied for 2
hours at room temperature (PDGFRb, dilution 1:500;
ab32570; Abcam, Cambridge, UK) or overnight at 4C
(GR1, dilution 1:750; MAB1037; R&D, Abingdon, UK;
F4/80, dilution 1:200; ab6640; Abcam). Secondary antibody
(PDGFRbebiotinylated goat anti-rabbit, dilution 1:1000;
BA-1000; Vector Laboratories; GR1ebiotinylated goat
anti-rat, dilution 1:1000; BA-9401; F4/80ebiotinylated
rabbit anti-rat, dilution 1:200; BA-4001) was applied for 30
minutes at room temperature. Detection was performed by
using the Elite Vectastain ABC kit and 3,30-diamino-
benzidine, before counterstaining, dehydration, and
mounting. For each sample, 10 sequential ﬁelds were ac-
quired at 20 magniﬁcation, and the percentage of positive
staining was calculated by using FIJI.36
b8 Integrin Subunit/Cleaved Caspase-3 IHC
Antigen retrieval was performed with Tris-EDTA (b8
integrin subunit) or sodium citrate (cleaved caspase-3),
endogenous peroxidases were quenched with 3% H2O2
before blocking with 20% horse serum. Primary antibody
(b8 integrin subunit, dilution 1:500; ab80673; Abcam;260Cleaved Caspase-3, dilution 1:1000; 9664; Cell Signaling
Technology, Leiden, The Netherlands) was applied over-
night at 4C. Detection was performed by using the Imm-
PRESS Polymerized Reporter Enzyme Staining System
(MP7401; Vector Laboratories) and 3,30-diaminobenzidine
before counterstaining, dehydration, and mounting.
Hematoxylin and Eosin Staining
Sections were baked at 55C overnight before de-waxing and
rehydration. Slides were then placed in Harris Hematoxylin
(Thermo Fisher Scientiﬁc, Paisley, UK) for 5 minutes. After
washing, slides were placed in 1% acid alcohol for 5 seconds,
followed by Scott’s tap water for 2 minutes. Slides were then
transferred to Eosin Y solution (Thermo Fisher Scientiﬁc) for
2 minutes, followed by washing, dehydration, and mounting.
For quantiﬁcation of mitotic ﬁgures, a minimum of 1000
hepatocytes were counted per sample.
Primary Mouse Hepatocyte Isolation
Primary mouse hepatocytes were isolated by retrograde
perfusion of the liver with Liver Perfusion Medium (Thermo
Fisher Scientiﬁc), followed by Liver Digest Medium
(Thermo Fisher Scientiﬁc) at 37C. When hepatocytes were
visually dispersed within the liver capsule, the liver was
removed to a sterile dish and minced with scissors to release
the crude cell isolate. The cells were then suspended in
Dulbecco’s modiﬁed Eagle’s medium/F-12 (Thermo Fisher
Scientiﬁc) and pelleted twice. Hepatocytes were puriﬁed
from the washed pellets by resuspension in culture medium
and centrifugation through 50% equilibrated Percoll (GE
Healthcare Life Sciences, Little Chalfont, UK).
Standard Primary Hepatocyte Culture
Primary hepatocytes were isolated as described in the sec-
tion above, resuspended in low-serum medium [Dulbecco’s
modiﬁed Eagle’s medium (Thermo Fisher Scientiﬁc), 2.5%
fetal bovine serum (Thermo Fisher Scientiﬁc), 2% L-gluta-
mine (Thermo Fisher Scientiﬁc), 1% penicillin streptomycin
(Thermo Fisher Scientiﬁc)], and plated onto collagen-coated
wells (Collagen Type I; Millipore, Watford, UK) in a 6-well
plate at a density of 500,000 cells per well. Either b8
integrin subunit blocking antibody26 or nonbinding control
antibody were added at 20 mg/mL, and samples were
incubated for 24 hours at 37C in 5% CO2. Wells were then
washed with phosphate-buffered saline (PBS), and cells
were lysed as described in the following section.
RT-qPCR
RNA was isolated from whole mouse liver, primary hepato-
cytes, or liver sinusoidal endothelial cells by using a RNeasy
Mini Kit (whole liver, hepatocytes) or Rneasy Plus Micro Kit
(liver sinusoidal endothelial cells; Qiagen, Manchester, UK).ajp.amjpathol.org - The American Journal of Pathology
Integrin avb8 and Liver RegenerationcDNA transcription and real-time quantitative PCR (qPCR)
were performed by using a SYBR-GreenER Two-Step qRT-
PCR kit (Invitrogen, Thermo Fisher Scientiﬁc) or QuantiTect
Reverse Transcription and SYBR Green PCR Kits (Qiagen).
Samples were ampliﬁed on an ABI 7900HT thermocycler
(Applied Biosystems, Thermo Fisher Scientiﬁc) and normal-
ized to Actb and/or Gapdh expression. Primers used were as
follows: Actb, 50TGTTACCAACTGGGACGACA-30 (for-
ward) and 50-GGGGTGTTGAAGGTCTCAAA-30 (reverse);
Itgb8, 50-CTGAAGAAATACCCCGTGGA-30 (forward) and
50-ATGGGGAGGCATACAGTCT-30 (reverse). Quantitect
Primer Assays (249990; Qiagen) were used for the following
genes: Ccna2 (QT00102151), Ccnb1 (QT00152040),
Ccnd1 (QT00154595), Ccne1 (QT00103495), Cdkn1a
(QT00137053), Cdkn1b (QT01058708), Gapdh
(QT01658692), and Plat (QT00133630).
To assess TGF-b signaling, a custom RT2 Proﬁler PCR
array (330171; Qiagen) was designed which contained
primer sequences for the genes shown in Supplemental
Table S1. RNA was isolated after primary hepatocyte
culture as described in the section above and reversed
transcribed by using the RT2 First Strand Kit (330401;
Qiagen). qPCR was performed by using RT2 SYBR Green
ROX qPCR Mastermix (330522; Qiagen) on an ABI
7900HT thermocycler, normalized to Actb and Gapdh
expression.
Hepatocyte Adhesion Assay
Adhesion was assessed by using a colorimetric ECM Cell
Adhesion Array Kit (ECM540; Millipore) according to the
manufacturer’s instructions. Primary mouse hepatocytes were
isolated as described above, plated in triplicate at 50,000 cells
per well, and incubated for 2 hours at 37C in 5% CO2.
Absorbance was measured at 570 nm by using a Synergy HT
microplate reader (BioTek, Swindon, UK). Relative absor-
bance was calculated by standardizing to absorbance in the
Collagen I well, before calculation of mean relative absor-
bance for each extracellular matrix protein for each sample.
Hepatocyte Proliferation Assay
Primary mouse hepatocytes were isolated as above and
plated at 10,000 cells per well in 24-well plates (353847;
Primaria; Corning, St David’s Park, UK) in Dulbecco’s
modiﬁed Eagle’s medium/F-12 supplemented with 15
mmol/L HEPES (H3375; Sigma-Aldrich), 10% fetal
bovine serum, 1% insulin-transferrin-selenium (41400-
045; Thermo Fisher Scientiﬁc), and 1% penicillin strep-
tomycin. Cells were allowed to adhere for 4 hours before
washing with PBS. Cells were then cultured for 48 hours
in a low-serum version of the plating medium, containing
only 0.5% fetal bovine serum. The b8 integrin subunit
blocking antibody or nonbinding control antibody was
added at 20 mg/mL. Growth factors [hepatocyte growth
factor (HGF), PHG0254, and epidermal growth factorThe American Journal of Pathology - ajp.amjpathol.org(EGF), PMG8044; Thermo Fisher Scientiﬁc] were added
at 40 ng/mL. Culture medium, antibodies, and growth
factors were refreshed at 24 hours, at which time 10 mmol/
L EdU (5-ethynyl-20-deoxyuridine; C10640; Thermo
Fisher Scientiﬁc) was added. After the 48-hour culture
period, cells were washed with PBS-BSA [PBS supple-
mented with 1% bovine serum albumin (BSA); A8806;
Sigma-Aldrich] and then ﬁxed by using 4% para-
formaldehyde in PBS for 15 minutes at room temperature.
Proliferating hepatocytes were detected by using the
Click-iT Plus EdU Alexa Fluor 647 Imaging Kit (C10640;
Thermo Fisher Scientiﬁc). Brieﬂy, ﬁxed cells were washed
with PBS-BSA and incubated in 0.5% Triton X-100
(T8787; Sigma-Aldrich) in PBS for 20 minutes at room
temperature. After washing, the Click-iT Plus reaction
cocktail was added, and cells were incubated for 30 minutes
at room temperature and protected from light. The cells
were washed again and then incubated in 5 mg/mL Hoechst
33342 (Thermo Fisher Scientiﬁc) for 30 minutes at room
temperature and protected from light. Finally, cells were
washed with PBS and imaged. Imaging was performed by
using an LSM780 confocal microscope system (Carl Zeiss
Ltd, Cambridge, UK). Tiled images were acquired, with
three non-overlapping areas of 18 mm2 imaged per well.
Imaris version 8.4.1 (Bitplane AG, Zurich, Switzerland) was
used to identify the total (Hoechst-positive) nuclei number
and the number of EdU-positive nuclei, and the percentage
of proliferating nuclei was calculated.
Whole Liver Microarray
Sample preparation, labeling, and array hybridizations were
performed by using the Agilent GE 4  44 Mouse micro-
array platform (Agilent Technologies, Palo Alto, CA). Total
RNA quality was assessed by using a Pico Chip on an
Agilent 2100 Bioanalyzer, and RNA was ampliﬁed and
labeled with cyanine 3ecytidine-50-triphosphate by using
the Agilent Technologies low RNA input ﬂuorescent linear
ampliﬁcation kits according to the manufacturer’s protocol.
Labeled cRNA was assessed by using the Nanodrop ND-
100 (Nanodrop Technologies, Inc., Wilmington DE), and
equal amounts of cyanine 3-labeled target were hybridized
to Agilent whole mouse genome 4  44K Ink-jet arrays
(G4122F; Agilent Technologies). Hybridizations were per-
formed for 14 hours, according to the manufacturer’s pro-
tocol. Arrays were scanned by using the Agilent
Technologies microarray scanner and raw signal intensities
were extracted with Agilent Feature Extraction version 10.5
software. Raw data are accessible at the Gene Expression
Omnibus repository (http://www.ncbi.nlm.nih.gov/geo;
accession number GSE111591).
Human Liver Tissue
De-identiﬁed sections of uninjured and ﬁbrotic human liver
tissue were provided by the Lothian NRS Bioresource261
Figure 1 Genetic depletion of hepatocyte integrin avb8 accelerated liver regeneration. A: Real-time quantitative PCR of Itgb8 expression in
hepatocytes isolated from control and Itgb8ﬂox/ﬂox;Alb-Cre (b8-AlbCre) mice. B: Quantitation of 5-bromo-20-deoxyuridine (BrdU)þ hepatocyte
nuclei in control and b8-AlbCre mice after partial hepatectomy. C: Representative images from BrdU immunostaining of liver sections from control
and b8-AlbCre mice at 0 and 48 hours after partial hepatectomy. D and E: Quantitation of hepatocyte mitoses (D) and liver-to-body weight ratio
(E) in control and b8-AlbCre mice after partial hepatectomy. F: Serum biochemistry [total bilirubin, alanine transaminase (ALT), alkaline
phosphatase (ALP), albumin] from uninjured control and b8-AlbCre mice. G and H: Quantiﬁcation and representative images from F4/80 (Kupffer
cell; G) and platelet-derived growth factor receptor (PDGFR)b (hepatic stellate cell; H) immunostaining of liver tissue from uninjured control
and b8-AlbCre mice. Data are expressed as means  SEM. n Z 3 control and b8-AlbCre mice (A); n Z 3 to 6 control and b8-AlbCre mice
per time point (BeE); n Z 6 control and b8-AlbCre mice (FeH). *P < 0.05, **P < 0.01, and ****P < 0.0001. Scale bars: 100 mm (C and G).
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Figure 2 Depletion of hepatocyte integrin
avb8 did not alter inﬂammatory phenotype after
partial hepatectomy. AeC: Quantiﬁcation and
representative images from F4/80 (Kupffer cell;
A), GR1 (neutrophil; B), and platelet-derived
growth factor receptor (PDGFR)b (hepatic stellate
cell; C) immunostaining of liver tissue from con-
trol and Itgb8ﬂox/ﬂox;Alb-Cre (b8-AlbCre) mice at
48 hours after partial hepatectomy. D: Quantita-
tion of 5-bromo-20-deoxyuridine (BrdU)þ hepato-
cyte nuclei and representative images of BrdU
immunostaining of liver tissue from control and
Itgb8ﬂox/ﬂox;Pdgfrb-Cre (b8-PdgfrbCre) mice at 48
hours after partial hepatectomy. Data are
expressed as means  SEM. nZ 5 control and b8-
AlbCre mice (AeC); n Z 4 and 8 control and b8-
PdgfrbCre mice (D). Scale bar Z 100 mm.
Integrin avb8 and Liver Regenerationwith approval from Tissue Governance. Samples of
acetaminophen-injured human liver tissue were obtained as
part of the Pathophysiology of Acute Liver Injury study.
This study was approved by the Scotland A Research Ethics
Committee and National Health Service Lothian Research
and Development.Statistical Analysis
The statistical signiﬁcance of differences between groups
was calculated with a two-tailed t-test or U-test as appro-
priate. Differences with a P value < 0.05 were considered
statistically signiﬁcant. PCR data obtained for individual
genes were log-transformed before analysis, and a Bonfer-
roni correction was applied to account for multiple testing.
PCR array data were standardized as previously reported,37
to identify genes in test samples with a 95% CI for stan-
dardized relative fold change that did not overlap 1 (the
value assigned to the fold change for the same gene in
control samples).
For microarray analysis, differential gene expression was
examined with the R package limma version 3.32.7.38
Quality control was performed by identifying outliers in
the log2 intensity between arrays and comparison of
multidimensional scaling of distances between microarrayThe American Journal of Pathology - ajp.amjpathol.orgexpression proﬁles. Background correction was conducted
according to the normexp method, and the data were
normalized by using the quantile normalization method.39,40
A two-way analysis of variance linear model was ﬁtted to
the comparison to estimate the mean M values and to
calculate moderated t-statistic, B statistic, false discovery
rate, and P value for each gene for the comparison of
interest. Adjusted P values were produced by the method
proposed by Holm.41 Gene Ontology (GO) analysis was
performed with the R package topGO version 2.28.0,42 and
the elim algorithm, combined with the Fisher exact test, was
used to calculate the enrichment scores for each of the GO
terms.Results
Depletion of Hepatocyte Integrin avb8 Leads to
Increased Hepatocyte Proliferation and Accelerated
Liver Regeneration
To deplete integrin avb8 in hepatocytes, Itgb8ﬂox/ﬂox;Alb-
Cre mice were generated.32,33 Primary hepatocytes were
isolated from Itgb8ﬂox/ﬂox;Alb-Cre mice and Cre-negative
littermate controls. qPCR for Itgb8 conﬁrmed expression
in control hepatocytes and successful depletion in263
Figure 3 Investigation of the mechanisms
mediating the pro-regenerative effect of hepato-
cyte integrin avb8 depletion. A and B: Whole liver
expression of cell cycle genes Ccna2 (A) and Ccnb1
(B) from control and Itgb8ﬂox/ﬂox;Alb-Cre (b8-
AlbCre) mice after partial hepatectomy. C: Iso-
lated hepatocytes from control and b8-AlbCre mice
were tested in a colorimetric extracellular matrix
adhesion assay. D: Whole liver expression of Itgb8
after partial hepatectomy. E: Schematic of exper-
imental design to test the effect of a b8 integrin
subunit blocking antibody on hepatocyte expres-
sion of transforming growth factor-beresponsive
genes. F: Fold regulation of genes from the real-
time quantitative PCR (qPCR) array with a
detectable change in hepatocyte expression after
culture with b8 integrin subunit blocking anti-
body. G: Proliferation of primary hepatocytes
cultured for 48 hours with b8 integrin subunit
blocking antibody or control antibody in culture
medium (Control) and with addition of either
epidermal growth factor (EGF) or hepatocyte
growth factor (HGF) or with both. Data are
expressed as means  SEM. n Z 4 to 6 control
and b8-AlbCre mice per time point (A and B);
nZ 4 control and b8-AlbCre mice (C); nZ 3 to 6
mice per time point (D); n Z 3 mice (F and G).
BSA, bovine serum albumin; Col, collagen.
Greenhalgh et alhepatocytes isolated from Itgb8ﬂox/ﬂox;Alb-Cre mice
(Figure 1A). Assessment of hepatocyte proliferation after
two-thirds partial hepatectomy showed signiﬁcantly
increased proliferation in Itgb8ﬂox/ﬂox;Alb-Cre mice at 36,
48, and 72 hours after liver injury compared with control
mice (Figure 1, B and C). This increased hepatocyte pro-
liferation was not followed by an increase in hepatocyte
apoptosis at day 5 after partial hepatectomy, when liver
regeneration was nearing completion in the Itgb8ﬂox/ﬂox;Alb-
Cre mouse (Supplemental Figure S1). Interestingly, the
proportion of hepatocyte mitoses (identiﬁed morphologi-
cally) was decreased in Itgb8ﬂox/ﬂox;Alb-Cre mice at 72
hours after liver injury compared with control mice
(Figure 1D). However, liver-to-body weight ratio was
signiﬁcantly increased in Itgb8ﬂox/ﬂox;Alb-Cre mice at 72
and 96 hours after partial hepatectomy, demonstrating that
the increase in hepatocyte proliferation in Itgb8ﬂox/ﬂox;Alb-
Cre mice detected by BrdU IHC resulted in accelerated264restoration of liver mass compared with control mice
(Figure 1E).
Depletion of Hepatocyte Integrin avb8 Does Not Alter
Baseline Hepatocyte Proliferation or Subsequent
Inﬂammatory Phenotype
Because integrin avb8 is able to activate TGF-b, a well-
characterized suppressor of epithelial proliferation, the ef-
fect of genetic depletion of hepatocyte avb8 on baseline
hepatocyte proliferation or liver-to-body weight ratio was
assessed. Hepatocyte BrdU incorporation and mitoses and
liver-to-body weight ratio were measured in uninjured
Itgb8ﬂox/ﬂox;Alb-Cre mice and control mice (Figure 1, B, D,
and E), and no difference was found in any of these vari-
ables between groups. Furthermore, no difference was
found in baseline liver biochemistry, hepatic morphology,
or resident nonparenchymal cell populations [Kupffer cellsajp.amjpathol.org - The American Journal of Pathology
Figure 4 Microarray analysis of whole liver (uninjured
and 24 hours after partial hepatectomy) from control and
Itgb8ﬂox/ﬂox;Alb-Cre (b8-AlbCre) mice. A: Summary of the
number of transcripts with signiﬁcant changes in expres-
sion after partial hepatectomy in b8-AlbCre and control
mice. B and C: The top 10 Gene Ontology (GO) terms
enriched in those genes either up-regulated (B) or down-
regulated (C) exclusively in b8-AlbCre mice after partial
hepatectomy. nZ 4 control and b8-AlbCre mice per group
per time point.
Integrin avb8 and Liver Regenerationand hepatic stellate cells (HSCs)] between uninjured
Itgb8ﬂox/ﬂox;Alb-Cre mice and control mice (Figure 1, FeH,
Supplemental Figure S2). After partial hepatectomy, no
difference was found in hepatic inﬂammation (Kupffer cells
or neutrophils) or HSC immunostaining (Figure 2, AeC).
This suggested that the increased liver regeneration
observed after partial hepatectomy in Itgb8ﬂox/ﬂox;Alb-Cre
mice was not due to differences in degree of initial injury or
the subsequent inﬂammatory response.
Depletion of HSC Integrin avb8 Does Not Lead to
Increased Hepatocyte Proliferation
Integrin avb8 is also expressed on HSCs.21 Because HSCs
have been shown to play an important regulatory role in
liver regeneration,43,44 mice in which integrin avb8 had
been depleted from HSCs (Itgb8ﬂox/ﬂox;Pdgfrb-Cre) were
used to examine the role of HSC integrin avb8 during liver
regeneration. After two-thirds partial hepatectomy, no sig-
niﬁcant difference was found in hepatocyte proliferation
between Itgb8ﬂox/ﬂox;Pdgfrb-Cre mice and control mice
(Figure 2D). Liver sinusoidal endothelial cells have alsoThe American Journal of Pathology - ajp.amjpathol.orgbeen shown to play a key role in liver regeneration.45e47
However, integrin avb8 expression was not observed in
liver sinusoidal endothelial cells by qPCR.
Assessment of Hepatic Cell Cycle Genes after Depletion
of Hepatocyte Integrin avb8 and Partial Hepatectomy
To examine whether depletion of hepatocyte integrin avb8
might have a direct effect on the cell cycle, the expression of
genes with key roles in cell cycle regulation was measured
at multiple time points after partial hepatectomy. Overall,
partial hepatectomy resulted in expected changes in gene
expression in whole liver from both Itgb8ﬂox/ﬂox;Alb-Cre
mice and control mice (Figure 3, A and B, Supplemental
Figure S3). A trend toward increased expression of Ccna2
and Ccnb1 was found in Itgb8ﬂox/ﬂox;Alb-Cre mice
compared with control mice; however, this trend did not
reach statistical signiﬁcance at any time point (Figure 3, A
and B). Analysis of other cell cycleerelated genes (Ccnd1,
Ccne1, Cdkn1a, Cdkn1b) showed no difference between
Itgb8ﬂox/ﬂox;Alb-Cre mice and control mice (Supplemental
Figure S3).265
Figure 5 Depletion of hepatocyte integrin avb8 did not increase hepatocellular carcinoma (HCC) in mice, whereas human hepatocytes expressed integrin
avb8 in acute and chronic liver disease. A: Schematic of mouse model of HCC. B: Representative images of livers from control and Itgb8ﬂox/ﬂox;Alb-Cre (b8-
AlbCre) mice at harvest. C and D: Quantiﬁcation of tumor number (C) and median tumor size (D) in control and b8-AlbCre mice at 40 weeks (horizontal bar
indicates mean). E: Representative low- and high-power images of b8 integrin subunit immunostaining in uninjured human liver tissue, after acetaminophen
overdose, or in cirrhosis. n Z 16 and 14 control and b8-AlbCre mice (C and D); n Z 5 uninjured human liver tissue samples (E); n Z 5 acetaminophen
overdose samples (E); n Z 6 cirrhosis samples (E). Scale bars: 250 mm (top row; E); 100 mm (bottom row; E). DEN Z diethylnitrosamine.
Greenhalgh et alDepletion of Integrin avb8 on Hepatocytes Does Not
Alter Adhesion to Multiple Matrix Proteins Present in
Normal and Regenerating Liver
Integrin avb8 binds extracellular matrix ligands such as
vitronectin, ﬁbronectin, collagen IV, and ﬁbronectin.48,49 To
test whether depletion of integrin avb8 on hepatocytes
altered adhesion to cell matrix proteins present in normal
and regenerating liver, an in vitro cell adhesion assay with
multiple different matrix substrates was used. No difference
was found in adhesion between Itgb8ﬂox/ﬂox;Alb-Cre and
control hepatocytes across all seven matrix proteins tested
(Figure 3C), suggesting that altered hepatocyte adhesion
was not responsible for the pro-regenerative phenotype
observed in Itgb8ﬂox/ﬂox;Alb-Cre mice.266Inhibition of Integrin avb8 Modulates TGF-b-
Responsive Genes in Hepatocytes
Integrin avb8 has previously been shown to play a key role
in the activation of latent TGF-b,25e31 a potent inhibitor of
hepatocyte proliferation.5e7 Therefore, we hypothesized
that depletion of hepatocyte integrin avb8 might promote
hepatocyte proliferation through modulation of TGF-b
signaling pathways. The time course of hepatic Itgb8
expression after partial hepatectomy supported a role for
integrin avb8 as a suppressor of hepatocyte proliferation
during liver regeneration (Figure 3D). Hepatic Itgb8
expression fell markedly in the 24 hours immediately after
partial hepatectomy, and this down-regulation appeared to
be permissive for hepatocyte proliferation. At the same timeajp.amjpathol.org - The American Journal of Pathology
Integrin avb8 and Liver Regenerationas the liver approached full restoration of its functional mass
at 5 days after partial hepatectomy, hepatocyte Itgb8
expression peaked at 10 times baseline expression, consis-
tent with a role for integrin avb8 as a brake on hepatocyte
proliferation (Figure 3D).
Detecting the modulation of TGF-b activation in the he-
patocyte regenerative niche is challenging, because it is not
possible to measure the levels of active TGF-b in tissue
directly. Therefore, an experiment was designed to examine
how inhibition of integrin avb8 might modulate TGF-
beresponsive genes in primary mouse hepatocytes
(Figure 3E). First, a custom qPCR array was designed,
containing 87 genes either shown to be responsive to TGF-b
signaling in hepatocytes50 or comprising components of the
TGF-b pathway (Supplemental Table S1). Primary murine
hepatocytes were isolated from wild-type mice and plated
onto collagen in the presence of either a b8 integrin subunit
blocking antibody or a nonbinding control antibody.26 After
incubation for 24 hours, hepatocytes were lysed, RNA was
extracted, and gene expression was quantiﬁed by using the
custom qPCR array. Data were then standardized as
previously described by Willems et al.37 After culture with
b8 integrin subunit blocking antibody, 20 genes in the
qPCR array were found to have a detectable change in
expression with a 95% CI, which did not overlap control
values (Figure 3F). Of these, 12 genes showed >10% up- or
down-regulation compared with controls, with 10 of 12
responding as predicted. Plat, encoding tissue plasminogen
activator (tPA), showed the greatest up-regulation. Hepa-
tocyte expression of Plat has been shown to decrease in the
presence of TGF-b,50 whereas expression increased three-
fold in wild-type hepatocytes treated with b8 integrin
subunit blocking antibody. Increased expression of Plat was
not observed when hepatocytes from Itgb8ﬂox/ﬂox;Alb-Cre
mice were treated with b8 integrin subunit blocking anti-
body, suggesting the observed response was speciﬁc to b8
integrin subunit inhibition (Supplemental Figure S4).
Conversely, hepatocyte expression of the TGF-
beresponsive gene Hmox1 (heme oxygenase 1) was down-
regulated in the presence of b8 integrin subunit blocking
antibody. These data indicated that inhibition of integrin
avb8 modulated TGF-beresponsive genes in hepatocytes,
suggesting a possible mechanism through which integrin
avb8 depletion promoted hepatocyte proliferation.
Inhibition of Hepatocyte Integrin avb8 Does Not Alter
the Proliferative Response to Mitogenic Growth Factors
HGF and EGF are key drivers of liver regeneration.8 To
investigate whether integrin avb8 might have a role in
regulating the hepatocyte response to these direct mitogens,
the effect of b8 integrin subunit inhibition during in vitro
proliferation of primary hepatocytes in response to EGF and
HGF was examined. A robust increase in hepatocyte pro-
liferation was achieved with addition of either EGF or HGF,
or with both, compared with standard culture mediumThe American Journal of Pathology - ajp.amjpathol.org(Figure 3G). However, inhibition of integrin avb8 had no
effect on the degree of in vitro hepatocyte proliferation. This
suggested that the accelerated liver regeneration observed
after hepatocyte integrin avb8 depletion did not occur via
modulation of HGF or EGF downstream signaling
pathways.
Microarray Analysis of Whole Liver from Control and
Itgb8ﬂox/ﬂox;Alb-Cre Mice
To explore further the potential mechanisms by which
inhibition of integrin avb8 increased hepatocyte prolifera-
tion and accelerated liver regeneration, global gene
expression changes were examined by microarray analysis
of whole liver. Samples were obtained from control and
Itgb8ﬂox/ﬂox;Alb-Cre mice before and at 24 hours after par-
tial hepatectomy. From 26,136 transcripts, 1080 showed
statistically signiﬁcant differential expression after
partial hepatectomy. Of these, 330 occurred only in the
Itgb8ﬂox/ﬂox;Alb-Cre mouse (Figure 4A). GO analysis was
performed on the differentially expressed genes. The
dominant GO terms enriched in genes up-regulated exclu-
sively in Itgb8ﬂox/ﬂox;Alb-Cre mice after partial hepatectomy
are shown in Figure 4B. Most terms related to cytoskeletal
organization and cellular adhesion. Similarly, the dominant
GO terms enriched in genes down-regulated exclusively in
Itgb8ﬂox/ﬂox;Alb-Cre mice after partial hepatectomy are
shown in Figure 4C. These terms were relatively nonspe-
ciﬁc, relating to a range of intracellular metabolic processes.
Given the increased hepatocyte proliferation observed
after partial hepatectomy in Itgb8ﬂox/ﬂox;Alb-Cre mice,
changes in expression of genes known to regulate the cell
cycle were speciﬁcally studied. However, when comparing
samples after partial hepatectomy from Itgb8ﬂox/ﬂox;Alb-Cre
mice and control mice, no signiﬁcant difference in the
expression of cell cycle genes was detected by microarray.
This mirrored the ﬁndings of both our examination of cell
cycle gene expression in whole liver before and after partial
hepatectomy (Figure 3, A and B and Supplemental
Figure S3) and the qPCR array in cultured hepatocytes
treated with b8 integrin subunit blocking antibody, in which
no consistent changes in gene expression were noted in the
10 cell cycle and proliferation genes included in the array
(Supplemental Table S1).
Depletion of Hepatocyte Integrin avb8 Does Not
Increase Tumor Formation in a Mouse Model of HCC
In addition to promoting hepatocyte proliferation, disruption
of TGF-b signaling can accelerate the development of
hepatocellular carcinoma (HCC) in mice after diethylnitros-
amine administration.12 Because depletion of integrin avb8
on hepatocytes increased hepatocyte proliferation and accel-
erated liver regeneration after injury, and blockade of hepa-
tocyte integrin avb8 in vitro modulated TGF-b-responsive
genes, the possibility that this pro-proliferative phenotype267
Greenhalgh et almight increase the risk of HCC development was also
assessed. Itgb8ﬂox/ﬂox;Alb-Cre and control mice were injected
with diethylnitrosamine at 12 to 14 days of age to induceHCC
(Figure 5A). After sacriﬁce at 40 weeks, the number and size
of tumors in each liver were quantiﬁed (Figure 5B). No dif-
ference was found in either tumor number or median tumor
size between Itgb8ﬂox/ﬂox;Alb-Cre and control mice (Figure 5,
C and D). This indicated that depletion of hepatocyte integrin
avb8 did not predispose to increased tumor formation in this
mouse model of HCC.
Human Hepatocytes Express Integrin avb8 and
Represent a Viable Therapeutic Target to Promote Liver
Regeneration in Patients with Liver Disease
To assess the potential utility of integrin avb8 as a thera-
peutic target to promote hepatocyte proliferation and liver
regeneration in patients with liver disease, the expression of
integrin avb8 was assessed in samples of human liver.
Uninjured liver tissue and tissue obtained from patients with
acute liver failure secondary to acetaminophen overdose or
from patients with cirrhosis were stained for the b8 integrin
subunit. Widespread expression in hepatocytes was detected
in all samples, demonstrating that integrin avb8 could be a
viable potential therapeutic target in patients with a broad
range of liver diseases (Figure 5E).Discussion
We show that depletion of hepatocyte integrin avb8 leads to
increased hepatocyte proliferation and accelerated liver
regeneration after partial hepatectomy in mice. The time
course of hepatic Itgb8 expression after partial hepatectomy,
namely a rapid down-regulation followed by rebound
up-regulation as the liver returns to its normal size, is
consistent with a role for integrin avb8 as a brake on
hepatocyte proliferation. This anti-proliferative role for
integrin avb8 appears to be mediated via TGF-b, rather than
altered hepatocyte adhesion, because blocking integrin
avb8 on hepatocytes alters TGF-beresponsive gene
expression. Of importance, the augmentation in hepatocyte
proliferation in Itgb8ﬂox/ﬂox;Alb-Cre mice was not accom-
panied by increased susceptibility to hepatocellular tumor
formation. Finally, human hepatocytes also express integrin
avb8 in both acute and chronic liver disease; therefore,
integrin avb8 represents a viable therapeutic target to pro-
mote liver regeneration in patients with a broad range of
liver diseases.
Integrin avb8 has previously been shown to have a key
regulatory role in the activation of latent TGF-b.25e31 The
inhibitory effect of active TGF-b on hepatocyte proliferation
is well established, including evidence demonstrating tonic
inhibition of hepatocyte proliferation in the uninjured
liver.5e7 The rapid down-regulation of hepatic Itgb8
expression observed after partial hepatectomy is in line with268the hypothesis that a reduction in integrin avb8-mediated
activation of TGF-b is permissive for a pro-regenerative
environment in the liver. To demonstrate subtle changes
in activation status of TGF-b within the hepatic regenerative
niche is challenging, given the magnitude and localized
nature of these changes and also the small amount of
remnant tissue present after two-thirds partial hepatectomy.
However, inhibition of hepatocyte integrin avb8 in vitro,
using a b8 integrin subunit blocking antibody, resulted in
changes in expression of multiple TGF-beresponsive genes
such as Plat and Hmox1. tPA, encoded by Plat, can activate
HGF51 and has been shown to play a role in liver lobule
reorganization after acute injury.52 Knockout of tPA in mice
worsens injury after bile duct ligation, but this phenotype is
reversed by administration of HGF.53 These data suggest
that the regulatory role of integrin avb8 during hepatocyte
proliferation is, at least in part, mediated via TGF-b
signaling and that integrin avb8 depletion or inhibition may
drive hepatocyte proliferation through tPA-mediated acti-
vation of HGF. Inhibition of hepatocyte integrin avb8 did
not alter the proliferative response to stimulation with EGF
and HGF in vitro, suggesting that the accelerated liver
regeneration observed after hepatocyte integrin avb8
depletion does not occur via modulation of HGF or EGF
downstream signaling pathways.
Detectable changes in the expression of genes that regu-
late the cell cycle were identiﬁed after partial hepatectomy,
similar to those previously reported,54 but did not differ
between Itgb8ﬂox/ﬂox;Alb-Cre mice and control mice.
Inhibiting integrin avb8 in vitro also had no effect on
expression of cell cycle genes, as measured by qPCR gene
array. This would suggest that depletion of integrin avb8 on
hepatocytes does not appear to change the kinetics of cell
cycle regulation in the individual cell. Instead, depletion of
hepatocyte integrin avb8 may promote liver regeneration by
permitting a greater number of hepatocytes to escape the
antiproliferative effects of active TGF-b. The observation of
a reduction in the proportion of hepatic mitoses in
Itgb8ﬂox/ﬂox;Alb-Cre mice compared with control mice at 72
hours after partial hepatectomy is difﬁcult to reconcile with
the increase in BrdU incorporation and the accelerated
restoration of total liver mass. Although no change was
detected in cell cycle kinetics, if the overall time in M phase
were reduced in hepatocytes of Itgb8ﬂox/ﬂox;Alb-Cre mice,
this could decrease the proportion of mitotic hepatocytes at
any single point in time. Previous work has demonstrated a
strong effect of circadian rhythm on hepatocyte entry into M
phase after partial hepatectomy in mice, an effect not seen
when assessing BrdU incorporation.55 However, in this
study, partial hepatectomy was always performed in the
morning and experimental order was randomized, so this
should not account for differences between Itgb8ﬂox/ﬂox;Alb-
Cre mice and control mice.
To screen for additional pathways that might be regulated
by integrin avb8, gene expression was assessed by using
microarray in whole liver samples from Itgb8ﬂox/ﬂox;Alb-Creajp.amjpathol.org - The American Journal of Pathology
Integrin avb8 and Liver Regenerationand control mice, comparing gene expression in uninjured
liver and 24 hours after partial hepatectomy. Despite
observing a large number of changes in gene expression
(330) after partial hepatectomy that were restricted to
Itgb8ﬂox/ﬂox;Alb-Cre mice, there were again no differences in
expression of genes that regulated the cell cycle or prolif-
eration compared with control mice. The failure to detect
changes in expression of genes that regulated the cell cycle
may also reﬂect limitations in sensitivity, particularly of the
microarray technique, when applied to whole liver lysates
from Itgb8ﬂox/ﬂox;Alb-Cre and control mice. Even after
partial hepatectomy, only a minority of hepatocytes will be
proliferating at any one time, and the presence of non-
parenchymal cell mRNA in the whole liver lysates that were
analyzed will further reduce the signal-to-noise ratio.
GO analysis of genes up-regulated only in Itgb8ﬂox/ﬂox;Alb-
Cre mice after partial hepatectomy returned multiple terms
that related to cytoskeletal organization and extracellular
adhesion. Integrins are well known for their role in extracel-
lular adhesion and their cytoplasmic domains can bind the
cytoskeleton.14 However, it has previously been suggested
that the cytoplasmic domain of the b8 subunit does not bind
the cytoskeleton.48 Furthermore, no difference was found in
the ability of hepatocytes isolated from Itgb8ﬂox/ﬂox;Alb-Cre
and control mice to adhere to multiple extracellular matrix
proteins found in both normal and regenerating liver.
Targeting of TGF-b pathways has been a major focus
of research across several ﬁelds, particularly in the context
of inﬂammation, wound healing, and oncogenesis. Un-
fortunately, global inhibition of TGF-b signaling can be
associated with serious, undesirable effects, including
excessive inﬂammation and development of neo-
plasia.10e12 This is highly likely to be due to the pleio-
tropic, context-dependent functions of TGF-b. Selective
targeting of TGF-b activation by inhibition of integrin
avb8 in the hepatic regenerative niche may potentially
avoid many of the adverse effects noted with paneTGF-b
blockade while still promoting the desired effects on he-
patocyte proliferation and liver regeneration. Of impor-
tance, these results did not demonstrate an increase in
either hepatic inﬂammation or carcinogenesis in mice after
depletion of hepatocyte integrin avb8.
Human hepatocytes express integrin avb8 in uninjured
liver after acute hepatic injury secondary to acetaminophen
overdose and also in cirrhosis. Therefore, hepatocyte
integrin avb8 appears to be a viable translational target.
There are potentially multiple clinical scenarios to which
integrin avb8 inhibition could be applied. For example,
using avb8 inhibition as a pro-regenerative therapy in the
setting of acute liver failure may obviate the requirement
for, or buy more time before, liver transplantation.
Furthermore, combination with antiﬁbrotic therapies could
permit the restoration of functional, parenchymal liver mass
in tandem with a reduction in ﬁbrosis in patients with
chronic liver disease. It might also allow more patients with
primary or metastatic liver cancer to be treated successfully.The American Journal of Pathology - ajp.amjpathol.orgConclusion
Depletion of integrin avb8 on murine hepatocytes leads to
increased hepatocyte proliferation and accelerated liver
regeneration. Targeting integrin avb8 may therefore repre-
sent a promising therapeutic strategy to drive liver regen-
eration in patients with a broad range of liver diseases.
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